CHCHD2 and metabolic dysfunction-associated steatotic liver disease: The top 15 enriched Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways (based on the P value) showed that CHCHD2 target genes were involved in 2 liver diseases: NAFLD and hepatocellular carcinoma (Figure 1E).